Patents by Inventor John Kerner

John Kerner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ultra-accurate object tracking using radar in multi-object environment
    Patent number: 11946996
    Abstract: Accuracy for detecting and tracking one or more objects of interest can be improved using radar-based tracking systems. In some examples, multiple radars implemented in a device can be used to transmit signals to, and receive signals from, the one or more objects of interest. To disambiguate an object of interest from undesired objects such as the hand of a user, the object of interest can include a transponder that applies a delay element to a signal received from a radar, and thereafter transmits a delayed return signal back to the radar. The delay produced by the delay element can separate the return signal from undesired reflections and enable disambiguation of those signals. Clear identification of the desired return signal can lead to more accurate object distance determinations, more accurate triangulation, and improved position detection and tracking accuracy.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: April 2, 2024
    Assignee: Apple, Inc.
    Inventors: Michael Kerner, John Zhonghua Wu, Michael Delishansky, Zohar Agon, Shachar Shayovitz, Michael Ney, Shay I. Freundlich
  • TYROSINE KINASE RECEPTOR ANTAGONISTS AND METHODS OF TREATMENT FOR PANCREATIC CANCER
    Publication number: 20120214758
    Abstract: A method of treatment is disclosed whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may be comprised of an injectable carrier and two or more tyrosine kinase receptor inhibitors which may be nordihydrogluaiaretic acid (NDGA) and doxyrubicine.
    Type: Application
    Filed: February 17, 2012
    Publication date: August 23, 2012
    Applicant: The Regents of the University of California
    Inventors: Ira GOLDFINE, John Kerner, Betty A. Maddux, Michael Campbell, Jack F. Youngren, Peter Kushner
  • Tyrosine kinase receptor antagonists and methods of treatment for breast cancer
    Patent number: 8143226
    Abstract: A method of treatment is disclosed whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may be comprised of an injectable carrier and two or more tyrosine kinase receptor inhibitors which may be nordihydroguaiarectic acid (NDGA) and doxorubicin.
    Type: Grant
    Filed: October 25, 2006
    Date of Patent: March 27, 2012
    Assignee: The Regents of the University of California
    Inventors: Ira Goldfine, John Kerner, Betty A. Maddux, Michael Campbell, Jack F. Youngren, Peter Kushner
  • INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS
    Publication number: 20090280112
    Abstract: Disclosed herein are methods and compositions for the treatment of prostate cancer with an IGF-1 receptor kinase inhibitor. Methods are also provided for the treatment of prostate cancer by identifying a level of IGF-1 receptor expression and making a decision whether to treat with an IGF-1 receptor kinase inhibitor.
    Type: Application
    Filed: May 1, 2009
    Publication date: November 12, 2009
    Inventors: IRA D. Goldfine, Jack F. Youngren, Michael J. Campbell, Betty A. Maddux, John A. Kerner, Charles J. Ryan
  • TYROSINE KINASE RECEPTOR ANTAGONISTS AND METHODS OF TREATMENT FOR PANCREATIC AND BREAST CANCER
    Publication number: 20070099847
    Abstract: A method of treatment is disclosed whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may be comprised of an injectable carrier and two or more tyrosine kinase receptor inhibitors which may be nordihydrogluaiaretic acid (NDGA) and doxyrubicine.
    Type: Application
    Filed: October 25, 2006
    Publication date: May 3, 2007
    Inventors: IRA Goldfine, John Kerner, Betty Maddux, Michael Campbell, Jack Youngren, Peter Kushner